Archive by category "News" (Page 2)

Matrix-Bio Names Goonewardene to Board of Directors

FORT WAYNE, IND., May 16, 2013 – Matrix-Bio, Inc., a diagnostics company that uses metabolite profiling to detect cancer and other diseases, has named Julie K. Goonewardene to its Board of Directors. Download PDF

Continue Reading

Posted May 6, 2013 by Matrix-Bio • No Comments


Matrix-Bio Signs Metabolomics Biomarker Licensing Agreement with Quest Diagnostics for Development of Breast Cancer Recurrence Test

FORT WAYNE, IND., April 11, 2013 – Matrix-Bio, Inc., a diagnostics company that uses metabolite profiling to detect cancer and other diseases, has signed an exclusive global licensing and marketing agreement for metabolomic biomarkers with Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services. Download PDF

Continue Reading

Posted April 11, 2013 by Matrix-Bio • No Comments


The Growing Role of Diagnostics in Healthcare

WASHINGTON, D.C., October 10, 2012 – Steve Rusckowski, President and Chief Executive Officer of Quest Diagnostics, delivered a keynote speech at the 2012 Lab Institute presenting his insight into the growing role of diagnostics in healthcare and revealing his family’s experience with breast cancer. Click to read a transcript of his speech. Link to Article

Continue Reading

Posted October 10, 2012 by Matrix-Bio • No Comments


Cancer Research Publishes Matrix-Bio’s Study on Detecting Breast Cancer Recurrence

WEST LAFAYETTE, IND., October 20, 2010 – Connie Krabbe understands the fear and foreboding breast cancer survivors feel when visiting their physicians for post-treatment check-ups. Two of her four sisters died of metastatic cancer related to breast cancer, enduring bone, brain, and ovarian cancer before succumbing to the disease in their early 50s. “The original (continued…)

Continue Reading

Posted October 20, 2010 by Matrix-Bio • No Comments


Main Street Venture Funds Invests in Breast Cancer Recurrence Test

WEST LAFAYETTE, IND., July 22, 2010 – Main Street Venture Fund has just given the estimated 200,000 women diagnosed with breast cancer each year new cause for hope. The Fort Wayne-based angel investment group is investing in Matrix-Bio, Inc., a Purdue Research Park company with new technology that shows great potential for early breast cancer (continued…)

Continue Reading

Posted July 22, 2010 by Matrix-Bio • No Comments


Purdue Research Park-Based Companies to Travel to Silicon Valley to Seek Funding

WEST LAFAYETTE, IND. & REDWOOD CITY, Calif.–(BUSINESS WIRE)–Representatives of two Purdue Research Park-based companies launched from research developed at Purdue University will travel to California’s Silicon Valley on May 18 to make formal presentations to venture capitalists. Link to Article

Continue Reading

Posted May 11, 2009 by Matrix-Bio • No Comments


To request information or an interview, contact:

Melanie Lux
PR & Marketing Director
Melanie@matrix-bio.com
803.331.4794


Matrix-Bio Overview Presentation

To download an overview presentation on Matrix-Bio, enter your email address and click Send Request.



Download Our Investor Profile

To download our Investor Profile, enter your email address and click Send Request.